Localization and functional significance of a polymorphic determinant in the third component of human complement.
A polymorphic epitope in the third component of human complement was studied. This allotypic system is distinct from the electrophoretically determined C3 S/F polymorphism and is defined by the recognition of one allotype by a monoclonal antibody. Allotypic protein variants, C3F+ (reactive with this antibody) and C3S- (non-reactive with the antibody), were purified. Deglycosylation studies and N-terminal sequencing of CNBr fragments, reactive with the antibody, revealed that the polymorphic epitope was present in a beta chain fragment of mol. wt 20,000. In the intact C3 molecule, this fragment is situated with N-terminus at residue No. 202, using the numbering of the cDNA derived amino acid sequence of human prepro C3. Addition of Fab fragments from the alloselective antibody preferentially inhibited the activity of C3F+ in a haemolytic assay which is selective for the C3 activity in the alternative complement pathway.
D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal / Q000276:immunology; D003176:Complement C3 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000276:immunology*; D003488:Cyanogen Bromide; D004591:Electrophoresis, Polyacrylamide Gel; D000939:Epitopes / Q000032:analysis*; D006801:Humans; D010446:Peptide Fragments / Q000276:immunology; D011110:Polymorphism, Genetic
D000911:Antibodies, Monoclonal; D003176:Complement C3; D000939:Epitopes; D010446:Peptide Fragments; D003488:Cyanogen Bromide